The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...
This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...
CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...
Research supports that both finasteride and dutasteride help treat hair loss, particularly when caused by androgenetic ...
DUBLIN, Dec. 9, 2025 /PRNewswire/ -- ProVerum Limited, a medical device company focused on innovative, safe and effective solutions for treating benign prostatic hyperplasia (BPH), today announced it ...
Background and aim: Benign prostatic hyperplasia (BPH) involves androgen-driven proliferation with reduced apoptosis. Current 5α-reductase inhibitors can cause adverse effects, motivating safer ...
WHITEVILLE – Columbus Regional Healthcare System announced that it is among the first in our region to offer Aquablation® therapy with the new HYDROS™ Robotic System, the next-generation platform to ...
Good day, and thank you for standing by. Welcome to the Profound Medical Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback